Does NITROGLYCERIN Cause Product solubility abnormal? 81 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Product solubility abnormal have been filed in association with NITROGLYCERIN (Glonoinum). This represents 1.1% of all adverse event reports for NITROGLYCERIN.
81
Reports of Product solubility abnormal with NITROGLYCERIN
1.1%
of all NITROGLYCERIN reports
0
Deaths
17
Hospitalizations
How Dangerous Is Product solubility abnormal From NITROGLYCERIN?
Of the 81 reports, 17 (21.0%) required hospitalization.
Is Product solubility abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NITROGLYCERIN. However, 81 reports have been filed with the FAERS database.
What Other Side Effects Does NITROGLYCERIN Cause?
Drug ineffective (1,269)
Fall (1,183)
Hypotension (1,086)
Pain (952)
Constipation (896)
Headache (890)
Dyspnoea (801)
Malaise (765)
Dizziness (717)
Fatigue (680)
What Other Drugs Cause Product solubility abnormal?
BUPRENORPHINE (498)
BUPRENORPHINE\NALOXONE (274)
POLYETHYLENE GLYCOL 3350 (220)
CHOLESTYRAMINE (193)
PATIROMER (107)
LEVOTHYROXINE (100)
SOMATROPIN (98)
EXENATIDE (97)
ESTRADIOL (94)
AMLODIPINE (76)
Which NITROGLYCERIN Alternatives Have Lower Product solubility abnormal Risk?
NITROGLYCERIN vs NITROUS
NITROGLYCERIN vs NITROUS\OXYGEN
NITROGLYCERIN vs NIVOLUMAB
NITROGLYCERIN vs NIVOLUMAB\RELATLIMAB-RMBW
NITROGLYCERIN vs NIZATIDINE